FDA Approves First Over-the-Counter Birth Control Pill, Opill

Set to be available from March 18, Opill offers a new level of convenience and autonomy for those seeking birth control.

Opill, the first FDA-approved over-the-counter birth control pill, will be available from March 18.
Opill is a progestin-only pill, offering a new convenient option for those seeking birth control without a prescription.
The pill's retail price is set at $19.99 for a one-month supply, with variations for longer supplies, though costs may vary by retailer.
Opill's introduction is seen as a significant step for reproductive autonomy in the U.S., despite concerns about accessibility and cost.
The move has sparked discussions on the broader implications for reproductive rights and healthcare access in the country.